Literature DB >> 8448662

Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex: alterations by ethanol in vitro and by chronic in vivo ethanol ingestion.

L D Snell1, B Tabakoff, P L Hoffman.   

Abstract

The effects of ethanol on the binding of [3H]MK-801, [3H]L-glutamate, [3H]glycine and [3H]CGS 19755 to the N-methyl-D-aspartate receptor were determined in membranes from mouse cortex and hippocampus. Under equilibrium conditions, ethanol in vitro (100 mM) did not alter the apparent affinity or binding site density for any of these ligands. However, in the presence of glutamate and the selective glycine antagonist, 5,7-dichlorokynurenic acid, ethanol inhibited the non-equilibrium binding of [3H]MK-801. This inhibition could be reversed in a time- and concentration-dependent manner by addition of glycine. These data suggest that ethanol may inhibit N-methyl-D-aspartate receptor-mediated responses by altering the kinetics of channel activation. Chronic in vivo ethanol ingestion by mice, that resulted in tolerance to and physical dependence on ethanol, produced an increased density of hippocampal [3H]MK-801 and [3H]L-glutamate binding sites, but not [3H]glycine or [3H]CGS 19755 binding sites. It is possible that chronic ethanol ingestion may influence the subunit composition of the NMDA receptor complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448662     DOI: 10.1016/0006-8993(93)90246-j

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release.

Authors:  Vladimir Chefer; Jennifer Meis; Grace Wang; Alexander Kuzmin; Georgy Bakalkin; Toni Shippenberg
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

Review 2.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

3.  An in vitro model for studying the effects of continuous ethanol exposure on N-methyl-D-aspartate receptor function.

Authors:  Vikas Nath; Jason C Reneau; Janet S Dertien; Rajiv G Agrawal; Ian Guerra; Yaminiben Bhakta; Kafayat Busari; Mary Kate Neumann; Susan E Bergeson; R Lisa Popp
Journal:  Alcohol       Date:  2011-09-17       Impact factor: 2.405

Review 4.  Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

Authors:  Barbara J Mason; Charles J Heyser
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

5.  N-methyl-D-aspartate receptor subunit expression in adult and adolescent brain following chronic ethanol exposure.

Authors:  J P Pian; J R Criado; R Milner; C L Ehlers
Journal:  Neuroscience       Date:  2010-07-17       Impact factor: 3.590

6.  Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures.

Authors:  J Kotlinska; S Liljequist
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

7.  Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice.

Authors:  Danielle Gulick; Thomas J Gould
Journal:  Alcohol Clin Exp Res       Date:  2007-09       Impact factor: 3.455

8.  The expression of NMDA receptor subunit mRNA in human chronic alcoholics.

Authors:  Justin P Ridge; Ada M-C Ho; David J Innes; Peter R Dodd
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Ethanol, sedative hypnotics, and glutamate receptor function in brain and cultured cells.

Authors:  B Tabakoff; P L Hoffman
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

10.  A novel alcohol-sensitive position in the N-methyl-D-aspartate receptor GluN2A subunit M3 domain regulates agonist affinity and ion channel gating.

Authors:  Hong Ren; Yulin Zhao; Man Wu; Robert W Peoples
Journal:  Mol Pharmacol       Date:  2013-07-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.